QNCX
Quince Therapeutics, Inc.
31.00$
+5.2%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | +13.3% | +268.6% | +76.6% | +3.6% | -49.1% | +84.0% | -42.2% | -23.7% | |
| – | – | – | – | – | – | – | – | – | |
| – | +10.8% | +199.6% | +102.9% | -0.8% | -58.6% | -62.5% | +96.8% | +90.3% | |
| – | +60.0% | +340.2% | +96.4% | +67.9% | -11.9% | -32.0% | -0.6% | -14.4% | |
| – | +16.9% | +223.2% | +101.4% | +14.5% | -42.4% | -33.4% | +65.5% | -12.2% | |
| – | – | – | – | – | – | – | – | – | |
| – | -41.8% | +128.6% | -6.6% | -81.8% | +52.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | -80.9% | -152.7% | – | -128.6% | – | – | – | +3,594.3% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.